Hearing impairment in very low birth weight infants incidence, risks factors analysis and follow up

Clinical Neonatology

Volumn 12, Issue 1, 2005, Pages 30-35

  Saw, Hean Pat ^b   Ho, Mao Lin ^b   Chen, Jia Yuh ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHENG CHING GENERAL HOSPITAL   (Taiwan)

Author keywords

Hearing impairment; Premature; Very low birth weight

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; GENTAMICIN; LUNG SURFACTANT; NITRIC OXIDE; OXYGEN; VANCOMYCIN;

ARTICLE; CEREBRAL PALSY; CONTROLLED STUDY; DISEASE SEVERITY; EARLY DIAGNOSIS; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; FOLLOW UP; GESTATIONAL AGE; GROUPS BY AGE; HEARING AID; HEARING IMPAIRMENT; HEARING TEST; HIGH RISK INFANT; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; LEUKOMALACIA; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NECROTIZING ENTEROCOLITIS; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS SYNDROME; RISK ASSESSMENT; SEIZURE; SEPSIS; SEX RATIO; SPEECH DISORDER; VENTILATOR; VERY LOW BIRTH WEIGHT;

EID: 34547762648     PISSN: 13813390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. McGettigan MC, Adolph VR, Ginsberg HG, Goldsmith JP. New ways to ventilate newborns in acute respiratory failure. Pediatr Clin North Am 1998;45: 475-509.
2. Mazzella M, Bellini C, Calevo MG, et al. A randomized control study comparing the infant flow driver with nasal continuous positive pressure in preterm infants. Arch Dis Childhood Fetal Neonatal Ed 2001; 85:F86-90.
3. Smyth RL. Inhaled nitric oxide treatment for preterm infants with hypoxic respiratory failure. Thorax 2000; 55:51-5.
4. Crowley PA. Antenatal corticosteroid therapy: a meta-analysis of the randomized trails, 1972-1994. Am J Obstet Gynecol 1995;173:322-5.
5. Jiang ZD, Brosi DM, Wilkinson AR. Hearing impairment in preterm very low birthweight babies detected at term by brainstem auditory evoked responses. Acta Paediatr 2001;90:1411-5.
6. Van Straaten HLM, Hille ETM, Kok JH, Verkerk PH and the Dutch NICU Neonatal Hearing Screening Working Group: Implementation of a nation-wide automated auditory brainstem response hearing screening programme in neonatal intensive care units. Acta Paediatr 2003;92:332-8.
7. Eggermont JJ, Salamy A.. Development of ABR parameters in a premature and term born population. Ear Hear 1998;9:283-9.
8. Sininger YS, Cone-Wesson B, Folsom RC, et al. Identification of neonatal hearing impairment. Auditory brain stem response in perinatal period. Ear Hear 2000;21:383-99.
9. Norton SJ, Gorga MP, Widen JE, et al. Identification of neonatal hearing impairment. A multicenter investigation. Ear Hear 2000;21:348-56.
10. Vohr B, Maxon A. Screening infants for hearing impairment. J Pediatr 1996;128:710-4.
11. Van Riper LA, Kileny PR. ABR hearing screening for high risk infants. Am J Otol 1999;20:516-21.
12. Meyer C, Witte J Hildmann A, et al. Neonatal screening for hearing disorder in infants at risk: incidence, risk factors and follow up. Pediatrics 1999; 104,900-4.
13. Kountakis SE, Skoulas I, Phillips D, Chang CY. Risk factors for hearing loss in neonates. A prospective study. Am J Otolaryngol 2002;23:133-7.
14. Joint Committee on Infant Hearing: 1994 Position Statement. Otolaryngol Head Neck Surg 1995;113: 191-6.
15. Ohler KH, Menke JA, Fuller L. Use of higher dose extended interval aminoglycosides in a neonatal intensive care unit. Am J of Perinatology 2000;17: 285-90.
16. de Hoog M, van Zanten BA, Hop WC, Overbosch E, Weisglas-Kuperus N, van den Anker JN. Newborn hearing screening: Tobramycin and vancomycin are not risk factors for hearing loss. J Pediatr 2003;142: 41-6.
17. Ertl T, Hadzsiev K, Vincze O, Pytel J, Szabol I, Sulyok E. Hyponatremia and sensorineural hearing loss in preterm infants. Biol Neonate 2001;79:109-12.
18. Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breastfed term and near term infants with marked hyperbilirubinemia. Pediatrics 2001;107:1075-80.
19. Sarici SU, Sendar MA, Korkmaz A, AAZS, et.al. Incidence, course and prediction of hyperbilirubinemia in near term and term newborns. Pediatrics 2004; 113:775-80.
20. Purdy IB, Newborn auditory follow up. Neonatal Ntew 2000;19:25-33.
21. Doyle KJ, Burggraaff B, Fujikawa S, Kim J. Newborn hearing screening by otoacoustic emissions and automated auditory brainstem response. Int J Pediatr Otorhinolaryngol 1997;41:111-9.
22. Yoshinaga-Itano C, Coulter D, Thomson V. Development outcomes of children with hearing loss in Colorado hospitals with and without universal newborn hearing screening programs. Semin Neonatal 2001;6:521-9.
23. Thompson DC, McPhillips H, Davis RL, et al. Universal newborn hearing screening: summary of evidence. JAMA 2001;286:2000-10.
24. Pruszewicz A, Pospiech I. Low birth weight as a risk factor of hearing loss. Scand Audiol 2001;30 (suppl 52):194-6.
25. Marlow ES, Hunt LP, Marlow N. Sensorineural hearing loss and prematurity. Arch Dis Child Fetal Neonatal Ed 2000;82:F141-4.
26. Yoon PJ, Price M, Gallagher K, Fleisher BE, Messner AH. The need for long term auditologic follow-up of neonatal intensive care unit (NICU) graduates. Int Pediatr Otorhinolaryngol 2003;67:353-7.
27. Vohr BR, Widen JE, Cone-Wesson B, et al. Identification of neonatal hearing impairment: Characteristics of infants in neonatal intensive care unit and well-baby nursery. Ear Hear 2000;21:373-82.